InvestorsHub Logo
Followers 369
Posts 10529
Boards Moderated 0
Alias Born 12/03/2009

Re: None

Thursday, 04/19/2018 9:20:23 AM

Thursday, April 19, 2018 9:20:23 AM

Post# of 328553
BIELS sales DROPPED over 10% in 2017 over 2016...They received FDA clearance in February of last year. 4th quarter sales were horrible, yet so many want to avoid pointing it out. So FDA or not, this is proof they dont get repeat customers. That would have at least had 2017 higher than 2016. The bulk of these sales are by shareholders.

They didnt even do $2 Million in sales for all of 2017. WHAT A MESS.

2016 saw $2,089,694, while 2017 saw a losing $1,763,765

The 4th quarter was dismal at $464,782 and this included Holiday sales.

3rd quarter saw $458,264

2nd quarter saw $439,036

1st quarter was $401,683

https://backend.otcmarkets.com/otcapi/company/financial-report/190098/content

So the FDA did squat for them. And they didnt even reach the previous years sales. That mean same folks didngt buy, let alone adding new customers and most come back for a second device. These are gimmick products, that are Acti-CRAP

BUYER BEWARE HERE!!! This is a very well known family share selling scam. They are indicted by the SEC are are in current litigation becasue of it. Not a single share held by any institution, or any officers of the company.

With 20 Billion shares, 19.9 Billion in the FLOAT, this is a HUGE money LOSER.

You seriously dont want to buy into this mess. Cant hit $2 million in annual sales but has a 19.9 Billion float. Can you say way way way over priced?